Brooke L Slawinski1, Nicole Talge2, Brooke Ingersoll1, Arianna Smith3, Alicynne Glazier2, Jean Kerver2, Nigel Paneth2,4, Karen Racicot3. 1. Department of Psychology, College of Social Sciences, Michigan State University, East Lansing, MI, USA. 2. Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI, USA. 3. Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA. 4. Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Abstract
PROBLEM: Autism spectrum disorder (ASD) is one of the most commonly diagnosed neurodevelopmental disorders in the United States. While ASD can be significantly influenced by genetics, prenatal exposure to maternal infections has also been implicated in conferring risk. Despite this, the effects of several important maternal pathogens, such as cytomegalovirus (CMV) and herpes simplex virus 2 (HSV2), remain unknown. METHOD OF STUDY: We tested whether maternal CMV and/or HSV2 sero-positivity was associated with ASD symptoms in children. ELISA was used to assay for CMV IgG and HSV2 IgG in serum from the mothers of 82 children whose ASD symptoms were assessed at 3-6 years of age using the Social Responsiveness Scale version 2 (SRS-2). RESULTS: Associations between maternal viral serostatus and SRS-2 scores were estimated using linear regression with covariate adjustments. The children of mothers sero-positive for CMV, but not for HSV2, had SRS-2 scores 3.6-4.2 points higher, depending on the adjustment model, than sero-negative women, a significant finding, robust to several statistical adjustments. CONCLUSION: Our results suggest that maternal CMV infections may influence ASD symptoms. These findings are being further evaluated in ongoing prospective studies with larger population samples.
PROBLEM: Autism spectrum disorder (ASD) is one of the most commonly diagnosed neurodevelopmental disorders in the United States. While ASD can be significantly influenced by genetics, prenatal exposure to maternal infections has also been implicated in conferring risk. Despite this, the effects of several important maternal pathogens, such as cytomegalovirus (CMV) and herpes simplex virus 2 (HSV2), remain unknown. METHOD OF STUDY: We tested whether maternal CMV and/or HSV2sero-positivity was associated with ASD symptoms in children. ELISA was used to assay for CMV IgG and HSV2 IgG in serum from the mothers of 82 children whose ASD symptoms were assessed at 3-6 years of age using the Social Responsiveness Scale version 2 (SRS-2). RESULTS: Associations between maternal viral serostatus and SRS-2 scores were estimated using linear regression with covariate adjustments. The children of mothers sero-positive for CMV, but not for HSV2, had SRS-2 scores 3.6-4.2 points higher, depending on the adjustment model, than sero-negative women, a significant finding, robust to several statistical adjustments. CONCLUSION: Our results suggest that maternal CMV infections may influence ASD symptoms. These findings are being further evaluated in ongoing prospective studies with larger population samples.
Authors: Joachim Hallmayer; Sue Cleveland; Andrea Torres; Jennifer Phillips; Brianne Cohen; Tiffany Torigoe; Janet Miller; Angie Fedele; Jack Collins; Karen Smith; Linda Lotspeich; Lisa A Croen; Sally Ozonoff; Clara Lajonchere; Judith K Grether; Neil Risch Journal: Arch Gen Psychiatry Date: 2011-07-04
Authors: Keely Cheslack-Postava; Elina Jokiranta; Auli Suominen; Venla Lehti; Andre Sourander; Alan S Brown Journal: Paediatr Perinat Epidemiol Date: 2013-11-08 Impact factor: 3.980
Authors: Noah J Sasson; Kristen S L Lam; Debra Childress; Morgan Parlier; Julie L Daniels; Joseph Piven Journal: Autism Res Date: 2013-02-20 Impact factor: 5.216
Authors: Nathalie Pizzato; Barbara Garmy-Susini; Philippe Le Bouteiller; Françoise Lenfant Journal: Am J Reprod Immunol Date: 2003-10 Impact factor: 3.886
Authors: Alan S Brown; Melissa D Begg; Stefan Gravenstein; Catherine A Schaefer; Richard J Wyatt; Michaeline Bresnahan; Vicki P Babulas; Ezra S Susser Journal: Arch Gen Psychiatry Date: 2004-08
Authors: Paula E Goines; Lisa A Croen; Daniel Braunschweig; Cathleen K Yoshida; Judith Grether; Robin Hansen; Martin Kharrazi; Paul Ashwood; Judy Van de Water Journal: Mol Autism Date: 2011-08-02 Impact factor: 7.509
Authors: Deborah L Christensen; Jon Baio; Kim Van Naarden Braun; Deborah Bilder; Jane Charles; John N Constantino; Julie Daniels; Maureen S Durkin; Robert T Fitzgerald; Margaret Kurzius-Spencer; Li-Ching Lee; Sydney Pettygrove; Cordelia Robinson; Eldon Schulz; Chris Wells; Martha S Wingate; Walter Zahorodny; Marshalyn Yeargin-Allsopp Journal: MMWR Surveill Summ Date: 2016-04-01
Authors: Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle Journal: Psychopharmacology (Berl) Date: 2019-05-28 Impact factor: 4.530
Authors: Diana K Haggerty; Rita S Strakovsky; Nicole M Talge; Courtney C Carignan; Alicynne N Glazier-Essalmi; Brooke R Ingersoll; Rajendiran Karthikraj; Kurunthachalam Kannan; Nigel S Paneth; Douglas M Ruden Journal: Neurotoxicol Teratol Date: 2021-01-05 Impact factor: 3.763
Authors: Rebekah L Petroff; Vasantha Padmanabhan; Dana C Dolinoy; Deborah J Watkins; Joseph Ciarelli; Diana Haggerty; Douglas M Ruden; Jaclyn M Goodrich Journal: Front Genet Date: 2022-03-31 Impact factor: 4.772
Authors: Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker Journal: Bull World Health Organ Date: 2020-03-25 Impact factor: 9.408
Authors: Ahmad Naqib Shuid; Putri Ayu Jayusman; Nazrun Shuid; Juriza Ismail; Norazlin Kamal Nor; Isa Naina Mohamed Journal: Int J Environ Res Public Health Date: 2021-03-10 Impact factor: 3.390